FISH, NGS and array resources

NGS advances: Efficient fusion event detection in haematological malignancy clinical research

Resource type: Application note

Technology: NGS

Application: Haematology

This study highlights the ability of the SureSeq™ Myeloid Fusion Panel to detect multiple fusions, identify breakpoints, and capture MECOM overexpression, so your lab can achieve higher efficiency sample classification with a single assay.

55 results

The value of MRD assessment in AML

Resource type: Article

Technology: NGS

Application: Haematology

View resource

The future of chronic lymphocytic leukaemia (CLL) genomics?

Resource type: Article

Technology: NGS

Application: Haematology

View resource

Target capture NGS for use in molecular-based research of myeloid MRD

Resource type: Scientific poster

Technology: NGS

Application: Haematology

View resource

Capturing fusions in haematological malignancies through targeted RNAseq

Resource type: Scientific poster

Technology: NGS

Application: Haematology

View resource

Sequencing depth vs. VAF sensitivity

Resource type: Article

Technology: NGS

Application: Haematology

View resource

NGS advances: Efficient fusion event detection in haematological malignancy clinical research

Resource type: Application note

Technology: NGS

Application: Haematology

View resource

Introduction to the SureSeq Myeloid Fusion NGS Panel

Resource type: OGT presentation

Technology: NGS

Application: Haematology

View resource

Detecting fusion events in AML with NGS

Resource type: Article

Technology: NGS

Application: Haematology

View resource

Using a targeted NGS approach to detect copy number alterations and gene variants in Chronic Lymphocytic Leukaemia (CLL)

Resource type: Scientific poster

Technology: NGS

Application: Haematology

View resource

Relevance of NGS-based MRD in AML and first experiences with the SureSeq Myeloid MRD Panel

Resource type: Customer presentation

Technology: NGS

Application: Haematology

View resource

Development of a target-capture NGS assay for use in molecular-based research of myeloid measurable residual disease (MRD)

Resource type: Scientific poster

Technology: NGS

Application: Haematology

View resource

Myeloid malignancies’ driver mutations - Part #2: KMT2A, a gene for epigenetic regulation

Resource type: Article

Technology: NGS

Application: Haematology

View resource

Welcome to our International website

FISH, NGS and array resources

NGS advances: Efficient fusion event detection in haematological malignancy clinical research

Filter by:

55 results

The value of MRD assessment in AML

The future of chronic lymphocytic leukaemia (CLL) genomics?

Target capture NGS for use in molecular-based research of myeloid MRD

Capturing fusions in haematological malignancies through targeted RNAseq

Sequencing depth vs. VAF sensitivity

NGS advances: Efficient fusion event detection in haematological malignancy clinical research

Introduction to the SureSeq Myeloid Fusion NGS Panel

Detecting fusion events in AML with NGS

Using a targeted NGS approach to detect copy number alterations and gene variants in Chronic Lymphocytic Leukaemia (CLL)

Relevance of NGS-based MRD in AML and first experiences with the SureSeq Myeloid MRD Panel

Development of a target-capture NGS assay for use in molecular-based research of myeloid measurable residual disease (MRD)

Myeloid malignancies’ driver mutations - Part #2: KMT2A, a gene for epigenetic regulation

Don't shoulder your lab's burden alone - our OGT experts are here to help